BIOSIMILAR ADVANTAGE Trademark

Trademark Overview


On Monday, January 16, 2017, a trademark application was filed for BIOSIMILAR ADVANTAGE with the United States Patent and Trademark Office. The USPTO has given the BIOSIMILAR ADVANTAGE trademark a serial number of 87303204. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, September 9, 2024. This trademark is owned by CVS Pharmacy, Inc.. The BIOSIMILAR ADVANTAGE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business marketing services in the fields of prescription drugs, biologics/biotechnology goods, and medical devices; conducting and coordinating marketing studies in the fields of prescription drugs, biologics/biotechnology goods, and medical devices; mail order services in the field of prescription drugs, biologics/biotechnology goods, and medical devices; mail order pharmacy services; business management of reimbursement programs and reimbursement reporting in the field of prescription drugs, biologics/biotechnology goods, and medical devices; accounts receivable management services; accounts receivable reporting services; business management, namely, establishment and administration of credit, payment, and collection policies for others; business services, namely, administration and coordination of healthcare assignment of benefits for others; business management, namely, the design and management of patient assistance programs in the fields of prescription drugs, biologics/biotechn...
biosimilar advantage

General Information


Serial Number87303204
Word MarkBIOSIMILAR ADVANTAGE
Filing DateMonday, January 16, 2017
Status710 - CANCELLED - SECTION 8
Status DateMonday, September 9, 2024
Registration Number5414193
Registration DateTuesday, February 27, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 17, 2017

Trademark Statements


Description of MarkThe mark consists of a design element that reflects two hexagons that have three lines on the outside perimeter of the two hexagons and two lines being inside the two hexagons, to the right of the design is the wording, "BIOSIMILAR ADVANTAGE".
Pseudo MarkBA BIO SIMILAR ADVANTAGE; B A
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness marketing services in the fields of prescription drugs, biologics/biotechnology goods, and medical devices; conducting and coordinating marketing studies in the fields of prescription drugs, biologics/biotechnology goods, and medical devices; mail order services in the field of prescription drugs, biologics/biotechnology goods, and medical devices; mail order pharmacy services; business management of reimbursement programs and reimbursement reporting in the field of prescription drugs, biologics/biotechnology goods, and medical devices; accounts receivable management services; accounts receivable reporting services; business management, namely, establishment and administration of credit, payment, and collection policies for others; business services, namely, administration and coordination of healthcare assignment of benefits for others; business management, namely, the design and management of patient assistance programs in the fields of prescription drugs, biologics/biotechnology goods, and medical devices
NOT AVAILABLE"BIOSIMILAR"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code035
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History


Party NameRXC ACQUISITION COMPANY
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLOUISVILLE, KY 40223

Party NameRXC ACQUISITION COMPANY
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLOUISVILLE, KY 40223

Party NameCVS Pharmacy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895

Party NameCVS Pharmacy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 19, 2017NEW APPLICATION ENTERED
Tuesday, January 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 25, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 31, 2017ASSIGNED TO EXAMINER
Monday, April 10, 2017NON-FINAL ACTION WRITTEN
Monday, April 10, 2017NON-FINAL ACTION E-MAILED
Monday, April 10, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 27, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 17, 2017PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 2, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, January 2, 2018USE AMENDMENT FILED
Tuesday, September 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 8, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 24, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 9, 2024CANCELLED SEC. 8 (6-YR)
Tuesday, January 16, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 23, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED